GlassScriptPhysician profile
Bruce A Orkin
NPI 1255341970
$4,442.40
in general payments reported to CMS, 2019-2025
20 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $1,914 · 2021: $212 · 2022: $239 · 2023: $244 · 2024: $405 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,169.67 | 2019-2020 | |
| Allergan, INC. | $881.31 | 2019-2020 | |
| Ethicon US, LLC | $440.08 | 2019-2025 | Megadyne, Proximate |
| Conmed Corporation | $394.05 | 2019-2025 | Airseal |
| W. L. Gore & Associates, INC. | $260.73 | 2022-2024 | Gore Enform Preperitoneal Biomaterial |
| Medtronic, INC. | $143.25 | 2023 | Signet |
| Thd America, INC. | $141.36 | 2022-2024 | |
| Stryker Corporation | $138.89 | 2019 | |
| Medical Device Business Services, INC. | $138.34 | 2024 | Enseal |
| Integra Lifesciences Corporation | $117.55 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Shire North American Group INC | $117.25 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $103.73 | 2019 | |
| Smith+Nephew, INC. | $101.10 | 2023 | Renasys Go V2 Home, Renasys, Pico 14 |
| Solventum Corporation | $85.69 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Innovation Technologies INC | $76.92 | 2024 | Irrisept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $54.95 | 2020 | |
| Covidien LP | $31.14 | 2019 | |
| Daiichi Sankyo INC. | $25.88 | 2024 | Injectafer |
| Qol Medical, LLC | $20.51 | 2025 | Sucraid |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Orkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.